Financial Year End | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 |
---|---|---|---|---|---|---|---|---|
Revenue | 1.67B | 1.37B | 1.25B | 988.30M | 854.40M | 827.50M | 713.20M | 574.70M |
Cost of Revenue | 1.14B | 949.70M | 860.90M | 650.30M | 542.60M | 549.80M | 467.40M | 395.50M |
Gross Profit | 530.20M | 421.80M | 386.20M | 338.00M | 311.80M | 277.70M | 245.80M | 179.20M |
Operating Expenses | 242.90M | 209.40M | 218.20M | 174.00M | 149.30M | 157.90M | 153.70M | 147.50M |
Selling, General & Admin | 216.30M | 189.70M | 167.10M | 151.80M | 127.10M | 135.10M | 131.00M | 119.80M |
Research & Development | 12.00M | 11.40M | 11.20M | 9.40M | 7.60M | N/A | N/A | N/A |
Other Operating Expenses | 26.60M | 19.70M | 51.10M | 22.20M | 22.20M | 22.80M | 22.70M | 27.70M |
Operating Income | 287.30M | 212.40M | 168.00M | 164.00M | 162.50M | 119.80M | 92.10M | 31.70M |
Other Expenses / Income | -66.90M | -66.80M | -44.80M | -54.70M | -22.20M | N/A | -26.50M | N/A |
Before Tax Income | 220.40M | 145.60M | 123.20M | 109.30M | 162.50M | 119.80M | 65.60M | 31.70M |
Income Tax Expenses | 54.90M | 29.60M | 8.80M | 9.20M | 39.40M | 23.70M | 30.40M | 11.80M |
Net Income | 165.50M | 116.00M | 114.40M | 100.10M | 123.10M | 96.10M | 35.20M | 19.90M |
Interest Expenses | 66.90M | 49.20M | 43.20M | 54.70M | N/A | N/A | N/A | N/A |
Basic Shares Outstanding | 133.00M | 93.50M | 39.50M | 39.40M | 39.43M | 34.29M | 34.29M | 34.29M |
Diluted Shares Outstanding | 134.10M | 93.80M | 39.50M | 39.50M | 39.43M | 34.29M | 34.29M | 34.29M |
EBITDA | 315.60M | 232.10M | 219.20M | 186.20M | 184.70M | 145.70M | 90.90M | 56.70M |
EBITDA Margin | 18.93% | 16.92% | 17.58% | 18.84% | 21.62% | 17.61% | 12.75% | 9.87% |
EBIT | 287.30M | 194.80M | 166.40M | 164.00M | 162.50M | 119.80M | 65.60M | 31.70M |
EBIT Margin | 17.24% | 14.20% | 13.34% | 16.59% | 19.02% | 14.48% | 9.20% | 5.52% |
Financial Year End | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 |